POSTMENOPAUSAL women who have had breast cancer are needed for a trial.Run by Ballarat Oncology and Haematology Services, the trial is giving local women the chance to be part of an international trial by the Australian New Zealand Breast Cancer Trials Group.Known as LATER, the trial is looking at whether breast cancer can be prevented from recurring.Women who had breast cancer more than five years ago and were given tablet medication such as tamoxifen or femara for at least four years may benefit.The trial is looking at whether the breast cancer treatment drug letrozole can prevent or delay breast cancer returning in women who have had hormone sensitive breast cancer in the past.Women joining the study take a tablet a day for five years if they are in the treatment group. They also have their bone health monitored and regular mammograms, plus clinical check-ups.More than 180 women have already joined the study, but a further 1500 are needed.The study will be closing to volunteers early next year. For more information, call 1800 039 634 or visit www.anzbctg.org